CytoMed GDTC Stock Deal Activity Slight Rise 20260416 Gevo Inc GEVO posts widerthanexpected Q4 2025 loss with shares slipping 116 percent in todays trading Xperi XPER Stock Analysis Buy or Sell Q4 2025 EPS Beats Forecasts